Acting in Time to Prevent Complications

Veintiuna horas de bloqueo equivalen al costo de adquisición de la insulina necesaria durante un año para los pacientes diabéticos, unos 12 millones de dólares», detalló el doctor Erick Robles.
In Cuba, the results of the 2019 National Health Survey placed the prevalence of Type 2 diabetes mellitus in the population at 10 percent. In 2025, the disease was the eighth leading cause of death in the country, though it also constitutes a major risk factor for other conditions that top that list.
Regarding the national situation, prevention strategies, limitations in guaranteeing certain medications and technologies, as well as ongoing research, Granma spoke with Dr. Erick Robles Torres, director of the Institute of Endocrinology and head of the National Endocrinology Group.
–What factors explain the behavior of diabetes in Cuba, and what are the main challenges it poses to the health system?
–Diabetes constitutes a health issue whose repercussions extend beyond the individual who suffers from it, as it also affects families and communities.
"On a global scale, estimates from the International Diabetes Federation indicate that one in nine adults—approximately 589 million people—lives with this disease. More than four in ten are unaware they have it, which increases the risk of serious complications and premature death.
"In Cuba, the prevalence of Type 2 diabetes stood at 10 percent, according to the results of the 2019 National Health Survey. Its pattern is linked to factors such as urbanization, population aging, declining levels of physical activity, and rising rates of overweight and obesity.
"We must also consider that diabetes mellitus ranked as the eighth leading cause of death in our country in 2025. However, its public health significance is even greater when taking into account that it serves as a risk factor for other diseases that appear among the leading causes of mortality."
–This year's theme emphasizes acting early. What role does Primary Health Care play in preventing and detecting the disease?
–Prevention does not begin in a laboratory, but rather in communities. Hence the predominant role of Primary Health Care in our country, whose promotion and prevention work forms an integrating axis in addressing non-communicable diseases.
"Promoting healthy lifestyles, with an emphasis on nutrition, physical exercise, and healthcare, is indispensable. It is also important to develop personalized approaches for individuals presenting risk factors such as high blood pressure, obesity, family history, or tobacco use.
"Cuba's incorporation into the HEARTS-D initiative reflects the country's commitment to improving care and closing existing gaps in the control of hypertension and diabetes.
"We also rely on a network of 18 Diabetes Care Centers (CAD), which promote metabolic control through interactive therapeutic education with patients. They also serve as teaching settings for training human resources and spaces where research is conducted to address the problems of this population.
"The country's first Diabetes Care Center was established by the Institute of Endocrinology in 1972, under the direction of Professor Antonio Márquez Guillén. Its model included intensive education, a one-week day-hospital admission, a basic course for people with diabetes and their families, as well as a daily guidance clinic also open to medical personnel. Those functions remain relevant today."
–How important is comprehensive, multidisciplinary care in improving the quality of life for those living with diabetes?
–The multidisciplinary diabetes mellitus clinic represents a model in which professionals from different specialties work in a coordinated manner to provide comprehensive evaluation and person-centered treatment.
"Its purpose is to address the disease from medical, nutritional, psychological, social, and communicational dimensions, with continuous follow-up that helps improve glycemic control and prevent complications.
"Restoring the presence of these clinics across the national territory is a necessity and one of the main tasks of the specialty's National Group."
–What are the main difficulties in securing the medications and technologies these patients need?
–Within the basic list of medications, we have sensitive products of high economic value that are essential for life. In the case of domestically produced drugs, manufacturing has been limited by a lack of imported raw materials.
"To illustrate the magnitude of the difficulties, 21 hours of the embargo are equivalent to the cost of purchasing the insulin needed for one year for diabetic patients—roughly 12 million dollars.
"Furthermore, there are technologies unavailable to our population. Such is the case with the FreeStyle continuous glucose monitoring system, developed by the U.S. multinational Abbott, which would humanize the monitoring of people with diabetes by avoiding the frequent finger pricks of self-monitoring through a long-lasting sensor.
"Patients with Type 1 diabetes also lack access to continuous insulin infusion pumps, devices useful for treating children whose condition is difficult to control.
"Despite these circumstances, we receive solidarity aid from various parts of the continent. We work as a team and apply an intersectoral approach to find alternatives. We also provide laboratory technological support to other institutions that lack that resource."
–What lines of research and innovation is the Institute of Endocrinology currently working on?
–Our mission is to promote and develop scientific research, technological innovation, medical care, and the training of high-quality human resources in the field of Endocrinology, in addition to serving as the national reference center for the specialty.
"Among the most established lines of research is the study of Type 2 diabetes mellitus and its complications. In this area, new therapeutic regimens are being evaluated, such as the combination of moringa with Metformin, as well as the effectiveness of Cuban products like Heberprot-P in treating diabetic retinopathy.
"We are also working on implementing the Pan American Health Organization's HEARTS program for controlling hypertension and diabetes at the primary care level.
"Regarding Type 1 diabetes and the pediatric population, projects focus on studying national incidence, insulin resistance, microalbuminuria, and the neurocognitive impact of the disease in children and adolescents. These studies are vital for detecting complications early and planning necessary resources.
"One outcome of this work is the development and validation of a national questionnaire that identifies individuals at risk of dysglycemia. It is a simple, rapid, non-invasive, reliable, and cost-effective tool currently being applied in various locations to evaluate its results and assess its potential integration into the diabetes program and family medicine."
–Given current limitations, what are the priorities for sustaining and improving care for people with diabetes?
–We have seized the opportunities presented by crises to improve our organization, efficiency, and effectiveness. One of the fundamental actions is preparing all workers in the system to seek alternative solutions to problems.
"The National Health System depends on a continuous supply of electricity. For that reason, we are conducting analyses to transform our energy matrix, with the support of local authorities and entities, the contribution of workers from non-state management forms, and the participation of international solidarity.
"We are also developing a comprehensive promotion and commercialization strategy inside and outside the country, encompassing medical care, academic services, and other healthcare provisions such as telemedicine.
"The high priority the State grants to health, along with the accessibility and equity of services, constitute strengths of our system. We have not stopped for a single day. We work with the conviction that acting together, with perseverance and discipline, is essential to turning ideas into results."
Add new comment